XML 60 R50.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders'/Member Deficit (Details) - $ / shares
1 Months Ended 6 Months Ended 12 Months Ended
May 07, 2018
Oct. 20, 2016
Apr. 26, 2018
Jul. 20, 2017
Jun. 30, 2018
Dec. 31, 2017
Feb. 28, 2018
Dec. 31, 2016
Stockholders'/Member Deficit (Textual)                
Common stock authorized         100,000,000 100,000,000   45,000,000
Common stock, par value         $ 0.001 $ 0.001   $ 0.001
Common stock, shares issued         8,014,994 7,864,994   5,216,565
Common stock, shares outstanding         8,014,994 7,864,994   5,216,565
Preferred stock authorized         10,000,000 10,000,000   5,000,000
Preferred stock, par value         $ 0.001 $ 0.001   $ 0.001
Preferred stock, shares issued          
Preferred stock, shares outstanding          
Exchange of shares of common stock           1,573,000    
Additional future issuance of restricted stock award shares         100,000      
Issuance of restricted stock award, shares 50,000   100,000          
Restricted common stock             250,000  
NeuroOne, Inc. [Member]                
Stockholders'/Member Deficit (Textual)                
Common stock, ownership percentage       100.00%        
Tendered for cancellation of shares       3,500,000        
Issuance of founders shares resulting from Merger of LLC and NeuroOne Inc           85,051    
Common stock issued as founders' shares   5,131,514            
Description of founders' shares subscription   NeuroOne issued 5,131,514 shares of common stock (as adjusted for the exchange ratio in connection with the Acquisition) as founders' shares to seven individuals. Three of those investors were officers of NeuroOne. NeuroOne recorded $9,050 of share subscription receivable for these stock issuances in 2016, which remained outstanding as of December 31, 2016. The shares were subscribed at value of $0.03 per share based on a valuation prepared by NeuroOne utilizing a weighted average market value of invested capital methodology. In June 2017, the purchase price owed by the seven individuals for the founders' shares of NeuroOne under their respective subscription agreements totaling $9,050 was forgiven by NeuroOne prior to the Acquisition.            
Restricted common stock       992,265